Product Information
OXAZEPAM 10 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.6884 per EA under NDC 00228206710. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
10 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228206710
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072253On Market Since
1/2/2007
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 10 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6884 per EA |
|---|---|
| All-time high | $0.9352 (Jan 13, 2021) |
| All-time low | $0.5167 (Jun 22, 2016) |
| 52-week high | $0.8622 |
| 52-week low | $0.6884 |
| Median price | $0.7605 |
| Average price | $0.7653 |
| Largest weekly change | +42.0% (Jul 21, 2021) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXAZEPAM 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 10 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.6884 per EA (NDC 00228206710), effective Jun 24, 2026.
How has the price of OXAZEPAM 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 10 MG CAPSULE has declined 11.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 10 MG CAPSULE?
Since Nov 28, 2013, the NADAC for OXAZEPAM 10 MG CAPSULE has ranged from a low of $0.5167 (Jun 22, 2016) to a high of $0.9352 (Jan 13, 2021), with a median of $0.7605 per EA.
Are there cheaper alternatives to OXAZEPAM 10 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXAZEPAM 10 MG CAPSULE, is $0.6695 per EA — about 3% below OXAZEPAM 10 MG CAPSULE.
Who manufactures OXAZEPAM 10 MG CAPSULE?
OXAZEPAM 10 MG CAPSULE (NDC 00228206710) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification